BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for AN2 Therapeutics, Inc. (ANTX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for AN2 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:29 pm
Sale		 2024-09-30 13G AN2 Therapeutics, Inc.
ANTX		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -1,563,963decrease
(Position Closed)		 Filing
2023-02-14
11:45 am
Sale		 2022-12-31 13G AN2 Therapeutics, Inc.
ANTX		 BIOTECHNOLOGY VALUE FUND L P 1,563,963
8.100%		 -52,702decrease
(-3.26%)		 Filing
2022-04-04
4:38 pm
Purchase		 2022-03-25 13G AN2 Therapeutics, Inc.
ANTX		 BIOTECHNOLOGY VALUE FUND L P 1,616,665
8.600%		 1,616,665increase
(New Position)		 Filing